Crawford Investment Counsel’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Buy |
287,812
+2,232
| +0.8% | +$116K | 0.26% | 87 |
|
|
2025
Q1 | $17.2M | Buy |
285,580
+32,970
| +13% | +$1.99M | 0.31% | 78 |
|
|
2024
Q4 | $17.3M | Buy |
252,610
+6,669
| +3% | +$456K | 0.31% | 80 |
|
|
2024
Q3 | $17.7M | Buy |
245,941
+40,434
| +20% | +$2.91M | 0.3% | 80 |
|
|
2024
Q2 | $14.2M | Buy |
205,507
+3,025
| +1% | +$210K | 0.27% | 79 |
|
|
2024
Q1 | $16.2M | Buy |
202,482
+60,374
| +42% | +$4.83M | 0.3% | 76 |
|
|
2023
Q4 | $15.6M | Buy |
142,108
+1,685
| +1% | +$185K | 0.31% | 73 |
|
|
2023
Q3 | $14.2M | Buy |
140,423
+3,350
| +2% | +$338K | 0.31% | 71 |
|
|
2023
Q2 | $18.6M | Sell |
137,073
-21,033
| -13% | -$2.86M | 0.38% | 67 |
|
|
2023
Q1 | $16.4M | Buy |
158,106
+11,900
| +8% | +$1.24M | 0.35% | 70 |
|
|
2022
Q4 | $13M | Sell |
146,206
-1,343
| -0.9% | -$119K | 0.28% | 77 |
|
|
2022
Q3 | $11.8M | Buy |
147,549
+9,458
| +7% | +$758K | 0.28% | 77 |
|
|
2022
Q2 | $13.2M | Buy |
138,091
+13,936
| +11% | +$1.33M | 0.29% | 79 |
|
|
2022
Q1 | $18.4M | Sell |
124,155
-3,025
| -2% | -$449K | 0.36% | 68 |
|
|
2021
Q4 | $18M | Sell |
127,180
-513
| -0.4% | -$72.7K | 0.34% | 65 |
|
|
2021
Q3 | $16.7M | Buy |
127,693
+10,083
| +9% | +$1.32M | 0.34% | 65 |
|
|
2021
Q2 | $16.2M | Buy |
117,610
+10,780
| +10% | +$1.48M | 0.33% | 67 |
|
|
2021
Q1 | $14M | Buy |
106,830
+58,185
| +120% | +$7.6M | 0.31% | 71 |
|
|
2020
Q4 | $5.45M | Buy |
48,645
+2,385
| +5% | +$267K | 0.13% | 102 |
|
|
2020
Q3 | $3.64M | Buy |
46,260
+8,850
| +24% | +$696K | 0.1% | 115 |
|
|
2020
Q2 | $2.69M | Buy |
37,410
+30,500
| +441% | +$2.2M | 0.08% | 134 |
|
|
2020
Q1 | $396K | Buy |
+6,910
| New | +$396K | 0.01% | 212 |
|